If the Food and Drug Administration approves nirsevimab, it will be the first medical intervention available in the U.S. that can protect infants from RSV.
from International: Top News And Analysis https://www.cnbc.com/2023/06/08/fda-advisors-recommend-astrazeneca-antibody-for-infants-for-rsv.html
Friday, June 9, 2023
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment